RxDoctor Payments Data
★ My doctorsLook up a doctor →

Carmelo Blanquicett

Hematology & Oncology · Tampa, FLNPI 1962846196

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $16,782 of the $24,026 with a category attached, or 69.8%. Novartis accounts for 68.1% of it on its own, with 53 other manufacturers making up the rest. Reporting peaked in 2021 at $13,567 and has fallen 78.1% since, to $2,974 in 2025.

$24,026in general payments, 2019–2025

Across 217 payments — averaging $110.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$16K
  • Histosonics, Inc.$2K
  • Incyte Corporation$453
  • AstraZeneca$407
  • Lilly USA, LLC$399
  • Daiichi Sankyo Inc.$391
  • plus $4K from 48 others

What the payments were for

  • Consulting fees$16,78270%
  • Food & beverage$5,43723%
  • Education$6113%
  • Other$1,1965%

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis59$16,368
Histosonics, Inc.1$2,000
Incyte Corporation9$453
AstraZeneca(2 entities)10$407
Lilly USA, LLC12$399
Daiichi Sankyo Inc.12$391
Genentech USA, Inc.2$300
Exelixis Inc.4$282
Bayer3$261
Pfizer11$254
Bristol Myers Squibb2$253
GSK5$181
Novocure Inc.3$170
AbbVie3$166
Johnson & Johnson(2 entities)6$151
Astellas Pharma US Inc2$137
Gilead(2 entities)4$129
Eisai Inc.5$118
Takeda Pharmaceuticals U.S.A., Inc.4$113
Sobi, Inc2$110
E.r. Squibb & Sons, L.L.C.5$101
Fennec Pharmaceuticals, Inc.4$97
Merck4$96
Array Biopharma Inc3$75
Springworks Therapeutics, Inc.3$73
Alnylam Pharmaceuticals Inc.3$72
Sumitomo Pharma America, Inc.3$63
Regeneron Healthcare Solutions, Inc.2$57
Stemline Therapeutics Inc.2$47
Kyowa Kirin, Inc.2$46
Pharmacosmos Therapeutics Inc.2$44
Amneal Pharmaceuticals LLC1$42
Pharmaessentia USA Corporation2$41
Tempus AI, Inc2$40
Janssen Scientific Affairs, LLC1$40
Legend Biotech USA Inc.1$32
Menarini Silicon Biosystems, Inc.1$31
Beone Medicines USA, Inc.1$30
Blueprint Medicines Corporation1$29
Deciphera Pharmaceuticals Inc.1$29
Rigel Pharmaceuticals, Inc.1$29
Geron Corporation1$25
Servier Pharmaceuticals LLC1$25
Accord Healthcare, Inc.1$24
Taiho Oncology, Inc.1$22
Beigene USA, Inc.1$22
Karyopharm Therapeutics Inc.1$21
Agios Pharmaceuticals, Inc.1$21
AVEO Pharmaceuticals, Inc.1$21
Telix Pharmaceuticals1$20
EMD Serono, Inc.1$19
Progenics Pharmaceuticals, Inc.1$18
Emmaus Medical, Inc.1$17
Seagen Inc.1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$24,026 in reported general payments places this provider in the 75th percentile of 694 hematology & oncology providers in Florida.

See all hematology & oncology providers in Florida →

Medicare billing

Part B allowed, 2024
$231,661
Medicare patients
17
Services billed
8,914

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Tampa

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →